BioCentury
ARTICLE | Financial News

Momenta, Global Blood price follow-ons

December 14, 2018 7:06 PM UTC

Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) and Global Blood Therapeutics Inc. (NASDAQ:GBT) each priced follow-ons, raising a total of $350 million.

Momenta raised $200 million Dec. 6 through the sale of 17.4 million shares at $11.50. The price is a 3% premium to Momenta's close of $11.17 on Dec 4. Momenta proposed to raise $150 million on Dec. 5 when U.S. markets were closed...

BCIQ Company Profiles

10x Genomics Inc.